BioLine RX Ltd (NASDAQ:BLRX)

4.49
Delayed Data
As of 3:59pm ET
 -0.1541 / -3.32%
Today’s Change
4.22
Today|||52-Week Range
27.60
-31.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-14.4M-15.9M-24.5M-22.9M
 
 
 
 
 
Depreciation440.8K483.5K484.4K543.2K
 
 
 
 
 
Total Other Cash Flow-362.9K436.4K682.8K-67.8K
 
 
 
 
 
Funds From Operations-14.3M-15.0M-23.4M-22.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-153.9K-412.3K-2.7M1.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-14.2M-14.6M-20.7M-24.1M
 
 
 
 
 
 
InvestingIncrease In Investments-63.1M-33.1M-45.3M-26.4M
 
 
 
 
 
Decrease In Investments50.2M42.5M33.6M46.1M
 
 
 
 
 
Capital Expenditures-2.7M-52.2K-340.4K-172.4K
 
 
 
 
 
Net Cash Flow Investing-15.6M9.3M-16.0M9.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings466.8K0.000.000.00
 
 
Long Term Debt Reduction-31.0K-93.3K-93.7K-409.7K
 
 
 
 
 
Net Proceeds Stock Sale29.0M2.2M39.0M3.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.009.6M
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing29.5M2.1M39.0M13.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash33.0K51.2K438.1K-165.5K
 
 
 
 
 
 
Net Change In Cash-278.9K-3.1M2.2M-1.5M